Elucidation of the regulatory mechanism for vascular endothelial growth factor (VEGF) expression in diabetic retinopathy
Elucidation of the regulatory mechanism for vascular endothelial growth factor (VEGF) expression in diabetic retinopathy
批准号:
11694267
负责人:
HONDA Yoshihito
金额:
$5.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
该研究的目的是阐明糖尿病视网膜病变早期的发病机制,并开发新的策略来阻止视网膜病变的发生。我们主要集中在血管生成和血管通透性因子,如血管内皮生长因子和血管生成素(Ang1,2)的分子机制。肾素-血管紧张素系统已被证明在视网膜病变的发生发展中起关键作用。我们的研究结果表明,ALL通过增加视网膜微血管周细胞分泌血管内皮生长因子和血管内皮细胞VEGFR2和Ang2来刺激血管异常。此外,ALL诱导的反应是通过AT1受体、PKC依赖的信号和AP1介导的转录调节来介导的。这些分子可能成为抑制视网膜病变早期事件的靶点。血管紧张素转换酶2也被证明会恶化内皮细胞与内皮细胞周围的相互作用。我们的研究表明,在体外或体内模型中,血管内皮生长因子、缺氧和糖尿病选择性地上调了Ang2的表达。这些发现可能提示该分子的上调可能是周细胞丢失的机制之一,周细胞丢失是一种重要的病理变化,被证明是促进血管增生性和血管通透性异常的触发因素。由于短期糖尿病动物视网膜中的白细胞行为与血管通透性反应有关,我们研究了一种机制,发现PKCβ特异性抑制白细胞的捕获和侵袭。综上所述,抑制血管内皮生长因子的调节机制和周细胞变性如ALL、Ang2和相关的信号系统可能是阻止视网膜病变早期病理事件的关键靶点。
英文摘要
The aim of the study is to elucidate the mechnaism of pathogenesis in early stages of diabetic retinopathy and to develop new strategies to halt the initiation of retinopathy. We mainly focused on the molecular mechanism associated with angiogenic and vasopermeable factors such as vascular endothelial growth factor (VEGF) and angiopoietins (Ang1, 2). Renin-angiotensin system has been shown to be a key player in the development of retinopathy. Our findings demonstrated that All stimulates the vascular abnormalities by increasing VEGF secretion in pericytes and VEGFR2 and Ang2 expression in endothelial cells in retinal microvasculature. In addition, the All-induced response is mediated through AT1 receptor, PKC dependent signaling, and AP1-mediated transcriptional regulation. These molecules could be targets to suppress early events of retinopathy. Ang2 has also been shown to deteriorate endo-periendothelial interaction. Our study revealed that Ang2 is seletively upregulated by VEGF, hypoxia, and diabetes mellitus in vitro or in vivo model. These findings might suggest that the upregulation of the molecule could be one of mechanisms on pericyte loss, which is a significant pathological change as shown to be a trigger to promote vasoproliferative and vasopermeable abnormalities. Since the leukocyte behavior is associated with vasopermeable response in the retina of short-term diabetic animal, we investigated a mechanism and found that PKCβ specific inhibition suppressed leukocyte trapping and invasion. Taken together, inhibition of regulatory mechnism of VEGF and pericyte degeneration such as All, Ang2, and the related-signaling system could be key targets to halt early pathological events of retinopathy
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
高木均: "虚血後の血管新生はどのようにして起こるのか"細胞工学特集「虚血分子メカニズムと新しい治療法」. 6 (2000)
Hitoshi Takagi:“缺血后血管生成如何发生?”细胞工程专题“缺血的分子机制和新的治疗方法”6(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Otani A: "Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes."Invest Ophthalmol Vis Sci.. 41. 1192-9 (2000)
Otani A:“牛视网膜周细胞中血管紧张素 II 刺激的血管内皮生长因子表达。”Invest Ophasemol Vis Sci.. 41. 1192-9 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suzuma K: "Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization."Microvasc Res.. 56. 183-91 (1998)
Suzuma K:“缺血诱导的视网膜新生血管小鼠模型中 KDR/Flk-1 (VEGFR-2) 的表达增加。”Microvasc Res.. 56. 183-91 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大谷篤史: "Expressions of angiopoietins and Tie 2 in human choroidal neovascular membranes"Invest Ophthalmol Vis Sci. 40. 1912-1920 (1999)
Atsushi Otani:“人脉络膜新生血管膜中血管生成素和 Tie 2 的表达”Invest Ophasemol Vis Sci 40。1912-1920 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Otani A. 他: "Angiotensin stimulates vascular endothelial growth factor expression in Dovine retinal microvascular cells"Invest Ophthalmol Vis Sci. (in press).
Otani A. 等人:“血管紧张素刺激Dovine 视网膜微血管细胞中血管内皮生长因子的表达”Invest Ophasemol Vis Sci(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
The investigation into an intreretinal pathology and a molecular biological mechanism of diabetic retinopathy
-
批准号:13307049
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$27.12万
-
财政年份:2001
-
负责人:HONDA Yoshihito
-
依托单位:
Targeted drug delivery using water-soluble polymer in the treatment of choroidal neovascularization.
-
批准号:10557154
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.19万
-
财政年份:1998
-
负责人:HONDA Yoshihito
-
依托单位:
The elucidation of molecular mechanism in delayed neruonal death and its control in rat retina
-
批准号:10307042
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$18.88万
-
财政年份:1998
-
负责人:HONDA Yoshihito
-
依托单位:
The study of the intracellular mechanism and its modulatory factor in the ischemic retina
-
批准号:08407055
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$19.71万
-
财政年份:1996
-
负责人:HONDA Yoshihito
-
依托单位:
The study of the intracellular mechanism of retinal neuronal death caused by ischemia
-
批准号:06404062
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$17.86万
-
财政年份:1994
-
负责人:HONDA Yoshihito
-
依托单位:
Development of a New System for Evaluation of Retinal Microcirculation with the Use of Heat-sensitive Liposomes
-
批准号:05557074
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$12.93万
-
财政年份:1993
-
负责人:HONDA Yoshihito
-
依托单位:
Studies on the electrolyte transport in corneal cells.
-
批准号:03044087
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.43万
-
财政年份:1992
-
负责人:HONDA Yoshihito
-
依托单位:
Pathophysiobgical Study of Retinal Ischenia-with Ion-seledive Microelectrode
-
批准号:03404051
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$11.52万
-
财政年份:1991
-
负责人:HONDA Yoshihito
-
依托单位: